Trigeminal Autonomic Cephalalgias, commonly referred to as TACs, represent a distinct group of primary headache disorders. What sets TACs apart from common tension headaches or standard migraines is their unique combination of severe, strict unilateral trigeminal pain accompanied by prominent cranial autonomic features on the same side as the pain. Patients experiencing a TAC attack present with symptoms like eye tearing (lacrimation), eye redness (conjunctival injection), nasal congestion, runny nose (rhinorrhea), or eyelid swelling (edema). Understanding these subtle variations is critical for accurate clinical diagnosis and tailored management plans.
The primary conditions classified under TACs include Cluster Headache, Paroxysmal Hemicrania, Short-lasting Unilateral Neuralgiform Headache Attacks (such as SUNCT and SUNA), and Hemicrania Continua. While they share overlapping features—such as unilateral orbital or temporal pain—they differ markedly in attack frequency, duration, gender distribution, and response to treatment.
For example, Cluster Headache affects males significantly more than females (with ratios ranging between 3:1 and 4.3:1) and involves severe stabbing pain lasting between 15 and 180 minutes. On the other hand, Paroxysmal Hemicrania exhibits a slight female predominance or equal ratio and causes shorter, more frequent attacks (lasting 2 to 30 minutes, occurring 1 to 40 times per day). SUNCT and SUNA represent even shorter bursts of burning or stabbing pain lasting anywhere from 1 to 600 seconds, with high daily attack frequencies reaching up to 200 times per day. Hemicrania Continua presents as a persistent, continuous pain with periodic exacerbations.
Another key differentiator among TACs is their responsiveness to specific medications. Paroxysmal Hemicrania and Hemicrania Continua display an absolute responsiveness to Indomethacin, which serves as both a diagnostic indicator and a primary treatment. Conversely, Cluster Headaches do not respond to Indomethacin and require acute interventions like high-flow normobaric oxygen or triptans, alongside preventive therapies like Verapamil. Recognizing these clinical distinctions ensures timely diagnosis and spares patients from ineffective treatments.